International Immunocompromised Host Society upcoming events

ICHS Webinar Resource Recording: Landscape of CMV Management in Transplant Recipients (15 Dec 2024)

Mon, 16 Dec 2024 05:00:00 GMT

ICHS Members: Complimentary -
Please log in first to register
as a member.

Early Career, Low/Middle Income Countries, Global Access: Complimentary - includes a one-year membership in ICHS.

Non-members: $25USD - includes a one year ICHS membership.

Exciting online session from ICHS offering education about the new advances in CMV management! This webinar provides dynamic, interactive content on the latest updates on CMV infections from updated guidelines to the utility of measuring CMV T Cell immunity to the burden of CMV post cellular therapy, based on needs assessments and questions from the attendees.

Access this resource for a comprehensive scientific session with insights into cutting-edge research, innovative care practices, and updated guidelines with a diverse range of experts.

Learn from the co-chair of the ECIL guidelines for CMV about the latest changes made since the last update.
Understand the role of CMV T Cell Immunity in mitigating the risk of CMV infections in Allogeneic Cell Transplant recipients.
Learn about the latest updates on risk of CMV infections after cellular therapy and its impact on oncologic outcomes.

Meet the Speakers:

Rafael de la Cámara, MD
Faculty Member, Hematology
Hospital de la Princesa
Hospital Universitario De La Princesa
Faculty Member
Hospital de la Zarzuela
Madrid, Spain

Biography for Dr. de la Camara - click here.

Joshua A. Hill, MD
Associate Professor, Department of Medicine, Division of Allergy and Infectious Diseases
University of Washington Medical Center
Assistant Professor, Vaccine and Infectious Disease Division, Clinical Research Division
Fred Hutchinson Cancer Center
Seattle, Washington USA

Biography for Dr. Hill - click here.

Michelle K. Yong, MBBS, FRACP, MPH, PhD
Infectious Diseases Physician
University of Melbourne
Peter MacCallum Cancer Centre
Melbourne, Australia

Biography for Dr. Yong - click here.

ICHS On Demand: Tuberculosis: Challenges, Innovations, and Future Directions (28 Apr 2025)

Tue, 29 Apr 2025 04:00:00 GMT

An ICHS online educational session for the care of immunocompromised patients!

ICHS Members: Complimentary
(Log in first for this option.)

Complimentary: Low/ middle income, early career and global access attendees.

Non-members: $25USD - includes a one year ICHS membership.

Speakers and ORCID's are available on the education page.

Supported by An Educational Grant From:

Sponsor Support:

Refunds must be requested within 48 hours in advance of the session. All refunds are subject to review and approval and will be issued after the event.

On Demand ICHS Early Career Networking Session (27 May 2025)

Wed, 28 May 2025 04:00:00 GMT

ICHS Early Career Opportunity!

Free for ICHS Members!

This dynamic ICHS online meeting was designed to advance Early Career education and career advancement opportunities.
The was an interactive collaboration session to engage with ICHS Council, global ambassadors, mentors and peers to exchange ideas, and help shape Early Career ICHS programs.

If you are an early career member and need assistance with your ICHS membership, please contact us.

On Demand: Breaking the Chain: Stopping Measles Before It Reaches the Most Vulnerable/ICHS in Collaboration with ESGREV from ESCMID (28 May 2025)

Thu, 29 May 2025 04:00:00 GMT

ICHS Members: Complimentary (Log in first for this option.)

Complimentary: Low/ middle income, early career and global access attendees.

Non-members: $25USD - includes a one year ICHS membership.

This informative session on measles is specifically tailored for healthcare professionals working with immunocompromised patients.

The session delves into the unique challenges and risks that measles poses to immunocompromised individuals, including those undergoing treatments such as chemotherapy, organ transplants, living with chronic conditions, or taking medications that weaken the immune system.

Explore the latest clinical features, epidemiology, and prevention strategies to effectively manage and mitigate the impact of measles in this vulnerable population.

Attendees will gain valuable insights into best practices for vaccination, post-exposure prophylaxis, and infection control measures to ensure the safety and well-being of immunocompromised patients.

Supported by An Educational Grant From:

On Demand ICHS Webinar: Dengue en el Inmunocomprometido: Cuando la Globalización es una Realidad. (01 Jun 2025)

Mon, 02 Jun 2025 04:00:00 GMT

This webinar is in Spanish.

Nueva oportunidad de seminario web educativo!

(Dengue in the Immunocompromised Host: When the Globalization Becomes a Reality.)

Acompáñanos en esta sesión sobre los desafíos del diagnóstico y manejo del dengue en pacientes inmunocomprometidos.

Webinars are offered as an on-demand resource following the session.

ICHS Members: Complimentary (Log in first for this option.)

Complimentary for Low/ middle income, early career and global access attendees.

Non-members: $25USD - includes a one year ICHS membership.

Conversando con expertos.

Session Details:

Coordinación Dra Patricia Costantini

Temas que se abordaran en una sesión interactiva

El cambio climático y la transmisión de virus re-emergentes en la región de las Americas
Dr Tomás Orduna

Impacto del Dengue en el paciente con cancer y TCPH
Dra Claudia Salgueira

Dengue y las transfusiones: cual es la real trascendencia?
Dr José Eduardo Levi

Implicancia de un brote de dengue en una Unidad de IC en Brasil
Dra Marjorie Vieira Batista

Moderator: Convener Patricia Costantini

The climate change and the transmission of reemerging viruses in the Americas
Dr Tomás Orduna

Impact of Dengue in the patient with cancer and HSCT
Dra Claudia Salgueira

Arbovirus and Blood transfusions
Dr José Eduardo Levi

Experience of a unit of immunocompromised patients during the outbreak of Dengue in Brazil
Dra Marjorie Vieira Batista

Supported by An Educational Grant From:

Refunds must be requested within 48 hours in advance of the session. All refunds are subject to review and approval and will be issued after the event.

On Demand ICHS Webinar: Transplant Donor Derived Infections: Theory to Practice (03 Jul 2025)

Fri, 04 Jul 2025 04:00:00 GMT

Free for ICHS members and most levels!

Free for Low/middle income, early career, global access attendees include a one-year membership

Non-members: $25 USD - includes a one-year membership

Webinar on Donor-Derived Infections: A Case-Based Approach

This interactive webinar will explore donor-derived infections in both solid organ transplantation and hematopoietic cell transplantation, offering dynamic content and expert insights.

Join a panel of leading experts for an engaging session featuring polling questions, expert perspectives, and innovative care strategies to enhance decision-making in donor-derived infections.

Agenda:

Current Knowledge & Best Practices – A summary of existing data in solid organ and hemopoietic cell transplantation.

Case-Based Discussions – Given the limited data, decisions are often made case by case. We will analyze real-world scenarios to discuss when to defer, when risks are acceptable, and how to respond when donor infections emerge post-transplant.

Audience-Driven Q&A – Expanding the discussion with questions submitted in advance and live inquiries during the session.

Objectives:

Review the current epidemiology and where to look for reliable data to rely on for our decision.
Identify how to make decisions through an interactive format.
Review where we have clear gaps, and unmet needs.
Discuss how we can improve knowledge in this field.

Please take advantage of these offerings which will provide you with the opportunity for future educational opportunities throughout the year.

If you need assistance with joining or renewing your membership, please contact us at the ICHS Office.

On Demand ICHS Webinar: New Updated CMV Guidelines from Two Continents: Impact on Clinical Care (10 Jul 2025)

Fri, 11 Jul 2025 04:00:00 GMT

New Educational On Demand Opportunity!

ICHS Members: Complimentary (Log in first for this option.)

Complimentary for Low/ middle income, early career and global access attendees.

Non-members: $25USD - includes a one year ICHS membership.

Click here for the webinar description and speaker Bios.

Refunds must be requested within 48 hours in advance of the session. All refunds are subject to review and approval and will be issued after the event.

On Demand_Invasive Fungal Diseases in Children: Strategies and Approach to Management (20 Oct 2025)

Mon, 20 Oct 2025 09:30:00 GMT

ICHS Members: Complimentary (Log in first for this option.)

Complimentary: Low/ middle income, early career and global access attendees.

Non-members: $25USD - includes a one year ICHS membership.

Please click here for the webinar program and speaker Bios.

Take advantage of this on demand informative session specifically tailored for healthcare professionals working with immunocompromised patients.

Supported by An Educational Grant From:

All refund requests are subject to review and approval.

On Demand: Managing Refractory and Resistant HSV Infections: Hope on the Horizon (17 Nov 2025)

Mon, 17 Nov 2025 15:00:00 GMT

Stay at the forefront of HSV care and improve patient outcomes.

ICHS Members: Complimentary (Log in first for this option.)

Complimentary: Early career and global access attendees.

Non-members: $25USD - includes a one year ICHS membership.

Click here for the program and speaker Bios.

Advance your expertise in HSV in this webinar designed specifically for all healthcare providers in the immunocompromised field. Learn directly from leading experts to clarify complex clinical scenarios.

The session included dynamic content from the advance needs assessment results, pre-webinar questions from registrant submissions, live polling, case discussions, and a panel Q&A session.

Objectives:

This session will provide you with the latest knowledge on HSV-1 and HSV-2 infections
Learn about the burden of severe HSV infections in immunosuppressed patient
Review a clinical case of a complicated HSV infection
Understand the role and the potential indications of new agents under investigation Current and emerging antiviral therapies and management strategies

Key Outcomes:

Gain updated practical knowledge on treating and managing HSV Improve diagnostic accuracy and patient counseling techniques Understand HSV’s clinical impact, including ocular, neurological, and neonatal risk Learn strategies to reduce viral transmission and improve patient outcomes

Join us for an informative session specifically tailored for healthcare professionals working with immunocompromised patients.

Supported by An Educational Grant From:

All refund requests are subject to review and approval.

ICHS: New Data Out of the Oven for Treatment of Herpes Simplex Infections (08 Jun 2026)

Mon, 08 Jun 2026 14:00:00 GMT

Stay at the forefront of HSV care and improve patient outcomes.

ICHS Members: Complimentary (Log in first for this option.)

Complimentary: Early career and global access attendees.

Non-members: $25USD - includes a one year ICHS membership.

Faculty Bios:

Dr. Papanicolaou

Dr. Shafat

Dr. Chemaly

Back from Holidays? So Are Your Patients! A Case-Based Approach to the Returning Immunocompromised Traveler: South America, the Middle East, and Asia (16 Sep 2026)

Wed, 16 Sep 2026 12:00:00 GMT

ICHS Members: Complimentary (Log in first for this option.)

Complimentary: early career and global access attendees.

Non-members: $25USD, includes a one year ICHS membership and access to all membership benefits.

Click here to check the time for your location.

Join ICHS for this webinar where we will present a case-based approach to evaluating immunocompromised travelers returning from South America, the Middle East, and Asia, with syndromes such as fever, rash, skin lesions, etc, focusing on locally prevalent arbovirus infections, bacterial and parasitic infections.

Participants will review region-specific and country-specific epidemiologic risks, differential diagnoses, practical approaches to diagnosis in non-endemic settings, treatment, and prevention.

Emphasis will be placed on how clinical presentation, diagnosis, prevention, and management of these travel-related infections might differ in immunocompromised populations (SOT/HCT/B-cell depletion) compared with immunocompetent travelers.

Learning Objectives

Differentiate the epidemiology, clinical manifestations, and diagnostic approach to key travel-related infections in immunocompromised travelers returning from South America, the Middle East, and Asia, with consideration of specific immunocompromised populations
Develop region-specific differential diagnoses for fever and common post-travel syndromes.
Apply evidence-based strategies for prevention, diagnostic evaluation, and management of travel-associated infections in immunocompromised.

Join us for an informative session specifically tailored for healthcare professionals working with immunocompromised patients.

Presenters (in alpha order)

Maha Alamri, MBBS, MSCI: Dr. Maha Alamri is a Transplant Infectious Disease Consultant at King Faisal Specialist Hospital and Research Center (KFHRC), in Riyadh, Saudi Arabia.

Gustavo Méndez, MD: Dr. Gustavo Méndez the is Head of the Department of Internal Medicine and staff physician of the Infectious Diseases Service of the Hospital Escuela de Agudos Dr. Ramón Madariaga de Posadas, Misiones, Argentina. He is a professor of Infectious Diseases at the Faculty of Medicine of the Catholic University of the Missions (UCAMI). He is a specialist in Infectious Diseases from the Faculty of Medicine of the University of Buenos Aires (UBA), Argentina.

Ban Hock Tan MBBS, (Singapore), MRCP (UK): Dr. Tan is a Senior Consultant in Infectious Diseases and Chief Quality Officer at Singapore General Hospital. A highly regarded leader in transplant infectious diseases, he played a key role in establishing the hospital’s Infectious Diseases department and advancing care for immunocompromised patients. He is a Clinical Professor at Duke-NUS Medical School and has held international leadership roles, including past president of the Transplant Infectious Disease Section of The Transplantation Society. His clinical expertise includes transplant infectious diseases, febrile neutropenia, and invasive fungal infections, and he has been recognized with national awards for clinical excellence and contributions to patient safety.

Siriorn Watcharananan, MD, FIDSA: Dr. Siriorn Watcharananan is an infectious disease specialist and Associate Professor of Medicine, Division of Infectious Disease, Department of Medicine at the Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Please contact admin@ichs.org if you need any assistance.

ICHS Webinar: Helicase-Primase Inhibitors for Refractory HSV: Clinical Evidence and Future Integration (01 Oct 2026)

Thu, 01 Oct 2026 13:00:00 GMT

This webinar will be a case-based educational webinar that transitions naturally into discussion of current evidence and future implementation of HPIs.

ICHS Members: Complimentary
(Log in first for this option.)

Complimentary: early career and global access attendees.

Non-members: $25USD - includes a one year ICHS membership.

Click here to check the time for your location.

Join ICHS for an interactive, case-based webinar where real-world scenarios set the stage for a dynamic discussion on the latest evidence and the outlook of Helicase Primase Inhibitors (HPIs). This session will reflect the evolution of the field with the future introduction of HPIs, the available clinical evidence, and how these therapies may be integrated into future practice.

Dr. Roy Chemaly will facilitate a moderated discussion with the presenters to provide attendees with both the scientific rationale and the clinical context for incorporating HPIs into future management strategies for Refractory HSV in immunocompromised patients.

During the webinar we will:

Analyze compelling cases that mirror major challenges

Explore current research shaping best practices

Envision practical strategies for future implementation

Webinar Agenda includes:

Case Presentation & Current Management – Dr. Joseph Sassine
Helicase-Primase Inhibitor Overview & Phase 2 Data – Dr. Camille Kotton
Phase 3 Clinical Evidence & Real-World Perspective - Dr. Zenia Papanicolaou
Moderated Discussion & Audience Q&A – Dr. Roy Chemaly

Whether you are looking to sharpen your clinical reasoning or stay ahead of emerging trends, this session offers evidence driven insight and actionable takeaways.

Reserve your spot today and be part of the conversation shaping tomorrow’s
HPI landscape.

Faculty (click here for Faculty Bios)

Dr. Roy F. Chemaly
UT MD Anderson Cancer Center

Dr. Camille Kotton
Massachusetts General Hospital
Harvard Medical School

Dr. Genovefa (Zenia) Papanicolaou
Memorial Sloan-Kettering Cancer Center
Weill Cornell Medical College

Dr. Joseph Sassine
OU College of Medicine
University of Oklahoma

International Immunocompromised Host Society upcoming events

ICHS Webinar Resource Recording: Landscape of CMV Management in Transplant Recipients (15 Dec 2024)

ICHS On Demand: Tuberculosis: Challenges, Innovations, and Future Directions (28 Apr 2025)

On Demand ICHS Early Career Networking Session (27 May 2025)

This dynamic ICHS online meeting was designed to advance Early Career education and career advancement opportunities. The was an interactive collaboration session to engage with ICHS Council, global ambassadors, mentors and peers to exchange ideas, and help shape Early Career ICHS programs.

On Demand: Breaking the Chain: Stopping Measles Before It Reaches the Most Vulnerable/ICHS in Collaboration with ESGREV from ESCMID (28 May 2025)

On Demand ICHS Webinar: Dengue en el Inmunocomprometido: Cuando la Globalización es una Realidad. (01 Jun 2025)

On Demand ICHS Webinar: Transplant Donor Derived Infections: Theory to Practice (03 Jul 2025)

On Demand ICHS Webinar: New Updated CMV Guidelines from Two Continents: Impact on Clinical Care (10 Jul 2025)

On Demand_Invasive Fungal Diseases in Children: Strategies and Approach to Management (20 Oct 2025)

On Demand: Managing Refractory and Resistant HSV Infections: Hope on the Horizon (17 Nov 2025)

ICHS: New Data Out of the Oven for Treatment of Herpes Simplex Infections (08 Jun 2026)

Back from Holidays? So Are Your Patients! A Case-Based Approach to the Returning Immunocompromised Traveler: South America, the Middle East, and Asia (16 Sep 2026)

ICHS Webinar: Helicase-Primase Inhibitors for Refractory HSV: Clinical Evidence and Future Integration (01 Oct 2026)

This dynamic ICHS online meeting was designed to advance Early Career education and career advancement opportunities.
The was an interactive collaboration session to engage with ICHS Council, global ambassadors, mentors and peers to exchange ideas, and help shape Early Career ICHS programs.